ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

ClinicalTrials.gov ID: NCT01396447

Public ClinicalTrials.gov record NCT01396447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 2:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar Depression

Study identification

NCT ID
NCT01396447
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Forest Laboratories
Industry
Enrollment
584 participants

Conditions and interventions

Interventions

  • Cariprazine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 25, 2011
Primary completion
Jan 9, 2014
Completion
Jan 9, 2014
Last update posted
Apr 30, 2018

2011 – 2014

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
36
Facility City State ZIP Site status
Forest Investigative Site 021 Birmingham Alabama 35216
Forest Investigative Site 017 Springdale Arkansas 72764
Forest Investigative Site 030 Beverly Hills California 90210
Forest Investigative Site 018 Cerritos California 90703
Forest Investigative Site 028 Costa Mesa California 92626
Forest Investigative Site 015 Oceanside California 92056
Forest Investigative Site 011 Temecula California 92591
Forest Investigative Site 012 Jacksonville Florida 32256
Forest Investigative Site 035 Orlando Florida 32806
Forest Investigative Site 013 Winter Park Florida 32789
Forest Investigative Site 038 Atlanta Georgia 30308
Forest Investigative Site 005 Atlanta Georgia 30328
Forest Investigative Site 029 Chicago Illinois 60640
Forest Investigative Site 024 Indianapolis Indiana 46260
Forest Investigative Site 031 Prairie Village Kansas 66206
Forest Investigative Site 041 Lake Charles Louisiana 70629
Forest Investigative Site 040 Shreveport Louisiana 71104
Forest Investigative Site 039 Flowood Mississippi 39232
Forest Investigative Site 026 Creve Coeur Missouri 63141
Forest Investigative Site 037 Las Vegas Nevada 89102
Forest Investigative Site 023 Cherry Hill New Jersey 08002
Forest Investigative Site 014 Marlton New Jersey 08053
Forest Investigative Site 006 Albuquerque New Mexico 87109
Forest Investigative Site 003 Brooklyn New York 11214
Forest Investigative Site 025 New York New York 10021
Forest Investigative Site 036 Canton Ohio 44718
Forest Investigative Site 008 Dayton Ohio 45417
Forest Investigative Site 042 Salem Oregon 97301
Forest Investigative Site 009 Allentown Pennsylvania 18104
Forest Investigative Site 010 Media Pennsylvania 19063
Forest Investigative Site 033 Lincoln Rhode Island 02865
Forest Investigative Site 019 Memphis Tennessee 38119
Forest Investigative Site 007 Dallas Texas 75231
Forest Investigative Site 016 Houston Texas 77008
Forest Investigative Site 027 Houston Texas 77054
Forest Investigative Site 020 San Antonio Texas 78229
Forest Investigative Site 043 Bellevue Washington 98007
Forest Investigative Site 032 Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01396447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2018 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01396447 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →